Thomas K. Hoffmann

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Ezra E.W. Cohen, Denis Soulières, Christophe Le Tourneau et al. · The Lancet · 2018 · 1.7K citations · Full text

Medicine, Oncology, Pharmacology +11

IL-31: A new link between T cells and pruritus in atopic skin inflammation

Enikö Sonkoly, Anja Müller, Antti Lauerma et al. · Journal of Allergy and Clinical Immunology · 2006 · 990 citations

Medicine, Dermatology, Immunology +16

Clinical Significance of PD-L1+ Exosomes in Plasma of Head and Neck Cancer Patients

Marie‐Nicole Theodoraki, Saigopalakrishna S. Yerneni, Thomas K. Hoffmann et al. · Clinical Cancer Research · 2017 · 615 citations · Full text

Medicine, Immunology, Oncology +17

Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema

Marco Cicardi, Aleena Banerji, Francisco Bracho et al. · New England Journal of Medicine · 2010 · 554 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +4

Combined analysis of HPV‐DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer

Niklas Reimers, H. Kasper, Soenke J. Weissenborn et al. · International Journal of Cancer · 2007 · 418 citations · Full text

Medicine, Oncology, Cancer Genetics +15